Clinical Trial Update: Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin [Phase 3]

View source ↗

Summary

A Phase 3 trial of sitagliptin for accelerated wound healing in diabetic foot ulcers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Wolfgang-Michael Franz | Conditions: Diabetic Foot | Phase 3 | Status: WITHDRAWN